Baseline PD-L1 expression and tumour-infiltrated lymphocyte status predict the efficacy of durvalumab consolidation therapy after chemoradiotherapy in unresectable locally advanced patients with non-small-cell lung cancer
Chemoradiotherapy (CRT) followed by durvalumab treatment improved prognosis in unresectable locally advanced non-small-cell lung cancer (LA-NSCLC). This study aimed to evaluate whether the status of the immune-related tumour microenvironment (TME) at baseline associates with the efficacy.
Gespeichert in:
| Autor*in: |
Shirasawa, Masayuki [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2022 |
|---|
| Schlagwörter: |
|---|
| Umfang: |
10 |
|---|
| Übergeordnetes Werk: |
Enthalten in: The effect of early cognitive therapy in improving cognitive functions using neuropsychology and diffusion tensor imaging measurements following mild traumatic brain injury: A pilot study - Hamzah, N. ELSEVIER, 2018, Amsterdam [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:162 ; year:2022 ; pages:1-10 ; extent:10 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.ejca.2021.11.013 |
|---|
| Katalog-ID: |
ELV056678592 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV056678592 | ||
| 003 | DE-627 | ||
| 005 | 20230624233618.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 220205s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ejca.2021.11.013 |2 doi | |
| 028 | 5 | 2 | |a /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001685.pica |
| 035 | |a (DE-627)ELV056678592 | ||
| 035 | |a (ELSEVIER)S0959-8049(21)01219-3 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q VZ |
| 084 | |a 44.52 |2 bkl | ||
| 100 | 1 | |a Shirasawa, Masayuki |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Baseline PD-L1 expression and tumour-infiltrated lymphocyte status predict the efficacy of durvalumab consolidation therapy after chemoradiotherapy in unresectable locally advanced patients with non-small-cell lung cancer |
| 264 | 1 | |c 2022 | |
| 300 | |a 10 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a Chemoradiotherapy (CRT) followed by durvalumab treatment improved prognosis in unresectable locally advanced non-small-cell lung cancer (LA-NSCLC). This study aimed to evaluate whether the status of the immune-related tumour microenvironment (TME) at baseline associates with the efficacy. | ||
| 650 | 7 | |a and PD-L1 expression |2 Elsevier | |
| 650 | 7 | |a Durvalumab |2 Elsevier | |
| 650 | 7 | |a Tumour-infiltrated lymphocytes |2 Elsevier | |
| 650 | 7 | |a CD8 |2 Elsevier | |
| 650 | 7 | |a Locally advanced non-small-cell carcinoma |2 Elsevier | |
| 700 | 1 | |a Yoshida, Tatsuya |4 oth | |
| 700 | 1 | |a Imabayashi, Tatsuya |4 oth | |
| 700 | 1 | |a Okuma, Kae |4 oth | |
| 700 | 1 | |a Matsumoto, Yuji |4 oth | |
| 700 | 1 | |a Masuda, Ken |4 oth | |
| 700 | 1 | |a Shinno, Yuki |4 oth | |
| 700 | 1 | |a Okuma, Yusuke |4 oth | |
| 700 | 1 | |a Goto, Yasushi |4 oth | |
| 700 | 1 | |a Horinouchi, Hidehito |4 oth | |
| 700 | 1 | |a Tsuchida, Takaaki |4 oth | |
| 700 | 1 | |a Yamamoto, Noboru |4 oth | |
| 700 | 1 | |a Nakayama, Yuko |4 oth | |
| 700 | 1 | |a Watanabe, Shun-ichi |4 oth | |
| 700 | 1 | |a Motoi, Noriko |4 oth | |
| 700 | 1 | |a Ohe, Yuichiro |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier |a Hamzah, N. ELSEVIER |t The effect of early cognitive therapy in improving cognitive functions using neuropsychology and diffusion tensor imaging measurements following mild traumatic brain injury: A pilot study |d 2018 |g Amsterdam [u.a.] |w (DE-627)ELV000241849 |
| 773 | 1 | 8 | |g volume:162 |g year:2022 |g pages:1-10 |g extent:10 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.ejca.2021.11.013 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 936 | b | k | |a 44.52 |j Therapie |x Medizin |q VZ |
| 951 | |a AR | ||
| 952 | |d 162 |j 2022 |h 1-10 |g 10 | ||
| author_variant |
m s ms |
|---|---|
| matchkey_str |
shirasawamasayukiyoshidatatsuyaimabayash:2022----:aeied1xrsinntmuiflrtdypoyettsrdctefiayfuvlmbosldtoteayfeceoaiteaynneetbe |
| hierarchy_sort_str |
2022 |
| bklnumber |
44.52 |
| publishDate |
2022 |
| allfields |
10.1016/j.ejca.2021.11.013 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001685.pica (DE-627)ELV056678592 (ELSEVIER)S0959-8049(21)01219-3 DE-627 ger DE-627 rakwb eng 610 VZ 44.52 bkl Shirasawa, Masayuki verfasserin aut Baseline PD-L1 expression and tumour-infiltrated lymphocyte status predict the efficacy of durvalumab consolidation therapy after chemoradiotherapy in unresectable locally advanced patients with non-small-cell lung cancer 2022 10 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Chemoradiotherapy (CRT) followed by durvalumab treatment improved prognosis in unresectable locally advanced non-small-cell lung cancer (LA-NSCLC). This study aimed to evaluate whether the status of the immune-related tumour microenvironment (TME) at baseline associates with the efficacy. and PD-L1 expression Elsevier Durvalumab Elsevier Tumour-infiltrated lymphocytes Elsevier CD8 Elsevier Locally advanced non-small-cell carcinoma Elsevier Yoshida, Tatsuya oth Imabayashi, Tatsuya oth Okuma, Kae oth Matsumoto, Yuji oth Masuda, Ken oth Shinno, Yuki oth Okuma, Yusuke oth Goto, Yasushi oth Horinouchi, Hidehito oth Tsuchida, Takaaki oth Yamamoto, Noboru oth Nakayama, Yuko oth Watanabe, Shun-ichi oth Motoi, Noriko oth Ohe, Yuichiro oth Enthalten in Elsevier Hamzah, N. ELSEVIER The effect of early cognitive therapy in improving cognitive functions using neuropsychology and diffusion tensor imaging measurements following mild traumatic brain injury: A pilot study 2018 Amsterdam [u.a.] (DE-627)ELV000241849 volume:162 year:2022 pages:1-10 extent:10 https://doi.org/10.1016/j.ejca.2021.11.013 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.52 Therapie Medizin VZ AR 162 2022 1-10 10 |
| spelling |
10.1016/j.ejca.2021.11.013 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001685.pica (DE-627)ELV056678592 (ELSEVIER)S0959-8049(21)01219-3 DE-627 ger DE-627 rakwb eng 610 VZ 44.52 bkl Shirasawa, Masayuki verfasserin aut Baseline PD-L1 expression and tumour-infiltrated lymphocyte status predict the efficacy of durvalumab consolidation therapy after chemoradiotherapy in unresectable locally advanced patients with non-small-cell lung cancer 2022 10 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Chemoradiotherapy (CRT) followed by durvalumab treatment improved prognosis in unresectable locally advanced non-small-cell lung cancer (LA-NSCLC). This study aimed to evaluate whether the status of the immune-related tumour microenvironment (TME) at baseline associates with the efficacy. and PD-L1 expression Elsevier Durvalumab Elsevier Tumour-infiltrated lymphocytes Elsevier CD8 Elsevier Locally advanced non-small-cell carcinoma Elsevier Yoshida, Tatsuya oth Imabayashi, Tatsuya oth Okuma, Kae oth Matsumoto, Yuji oth Masuda, Ken oth Shinno, Yuki oth Okuma, Yusuke oth Goto, Yasushi oth Horinouchi, Hidehito oth Tsuchida, Takaaki oth Yamamoto, Noboru oth Nakayama, Yuko oth Watanabe, Shun-ichi oth Motoi, Noriko oth Ohe, Yuichiro oth Enthalten in Elsevier Hamzah, N. ELSEVIER The effect of early cognitive therapy in improving cognitive functions using neuropsychology and diffusion tensor imaging measurements following mild traumatic brain injury: A pilot study 2018 Amsterdam [u.a.] (DE-627)ELV000241849 volume:162 year:2022 pages:1-10 extent:10 https://doi.org/10.1016/j.ejca.2021.11.013 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.52 Therapie Medizin VZ AR 162 2022 1-10 10 |
| allfields_unstemmed |
10.1016/j.ejca.2021.11.013 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001685.pica (DE-627)ELV056678592 (ELSEVIER)S0959-8049(21)01219-3 DE-627 ger DE-627 rakwb eng 610 VZ 44.52 bkl Shirasawa, Masayuki verfasserin aut Baseline PD-L1 expression and tumour-infiltrated lymphocyte status predict the efficacy of durvalumab consolidation therapy after chemoradiotherapy in unresectable locally advanced patients with non-small-cell lung cancer 2022 10 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Chemoradiotherapy (CRT) followed by durvalumab treatment improved prognosis in unresectable locally advanced non-small-cell lung cancer (LA-NSCLC). This study aimed to evaluate whether the status of the immune-related tumour microenvironment (TME) at baseline associates with the efficacy. and PD-L1 expression Elsevier Durvalumab Elsevier Tumour-infiltrated lymphocytes Elsevier CD8 Elsevier Locally advanced non-small-cell carcinoma Elsevier Yoshida, Tatsuya oth Imabayashi, Tatsuya oth Okuma, Kae oth Matsumoto, Yuji oth Masuda, Ken oth Shinno, Yuki oth Okuma, Yusuke oth Goto, Yasushi oth Horinouchi, Hidehito oth Tsuchida, Takaaki oth Yamamoto, Noboru oth Nakayama, Yuko oth Watanabe, Shun-ichi oth Motoi, Noriko oth Ohe, Yuichiro oth Enthalten in Elsevier Hamzah, N. ELSEVIER The effect of early cognitive therapy in improving cognitive functions using neuropsychology and diffusion tensor imaging measurements following mild traumatic brain injury: A pilot study 2018 Amsterdam [u.a.] (DE-627)ELV000241849 volume:162 year:2022 pages:1-10 extent:10 https://doi.org/10.1016/j.ejca.2021.11.013 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.52 Therapie Medizin VZ AR 162 2022 1-10 10 |
| allfieldsGer |
10.1016/j.ejca.2021.11.013 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001685.pica (DE-627)ELV056678592 (ELSEVIER)S0959-8049(21)01219-3 DE-627 ger DE-627 rakwb eng 610 VZ 44.52 bkl Shirasawa, Masayuki verfasserin aut Baseline PD-L1 expression and tumour-infiltrated lymphocyte status predict the efficacy of durvalumab consolidation therapy after chemoradiotherapy in unresectable locally advanced patients with non-small-cell lung cancer 2022 10 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Chemoradiotherapy (CRT) followed by durvalumab treatment improved prognosis in unresectable locally advanced non-small-cell lung cancer (LA-NSCLC). This study aimed to evaluate whether the status of the immune-related tumour microenvironment (TME) at baseline associates with the efficacy. and PD-L1 expression Elsevier Durvalumab Elsevier Tumour-infiltrated lymphocytes Elsevier CD8 Elsevier Locally advanced non-small-cell carcinoma Elsevier Yoshida, Tatsuya oth Imabayashi, Tatsuya oth Okuma, Kae oth Matsumoto, Yuji oth Masuda, Ken oth Shinno, Yuki oth Okuma, Yusuke oth Goto, Yasushi oth Horinouchi, Hidehito oth Tsuchida, Takaaki oth Yamamoto, Noboru oth Nakayama, Yuko oth Watanabe, Shun-ichi oth Motoi, Noriko oth Ohe, Yuichiro oth Enthalten in Elsevier Hamzah, N. ELSEVIER The effect of early cognitive therapy in improving cognitive functions using neuropsychology and diffusion tensor imaging measurements following mild traumatic brain injury: A pilot study 2018 Amsterdam [u.a.] (DE-627)ELV000241849 volume:162 year:2022 pages:1-10 extent:10 https://doi.org/10.1016/j.ejca.2021.11.013 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.52 Therapie Medizin VZ AR 162 2022 1-10 10 |
| allfieldsSound |
10.1016/j.ejca.2021.11.013 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001685.pica (DE-627)ELV056678592 (ELSEVIER)S0959-8049(21)01219-3 DE-627 ger DE-627 rakwb eng 610 VZ 44.52 bkl Shirasawa, Masayuki verfasserin aut Baseline PD-L1 expression and tumour-infiltrated lymphocyte status predict the efficacy of durvalumab consolidation therapy after chemoradiotherapy in unresectable locally advanced patients with non-small-cell lung cancer 2022 10 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Chemoradiotherapy (CRT) followed by durvalumab treatment improved prognosis in unresectable locally advanced non-small-cell lung cancer (LA-NSCLC). This study aimed to evaluate whether the status of the immune-related tumour microenvironment (TME) at baseline associates with the efficacy. and PD-L1 expression Elsevier Durvalumab Elsevier Tumour-infiltrated lymphocytes Elsevier CD8 Elsevier Locally advanced non-small-cell carcinoma Elsevier Yoshida, Tatsuya oth Imabayashi, Tatsuya oth Okuma, Kae oth Matsumoto, Yuji oth Masuda, Ken oth Shinno, Yuki oth Okuma, Yusuke oth Goto, Yasushi oth Horinouchi, Hidehito oth Tsuchida, Takaaki oth Yamamoto, Noboru oth Nakayama, Yuko oth Watanabe, Shun-ichi oth Motoi, Noriko oth Ohe, Yuichiro oth Enthalten in Elsevier Hamzah, N. ELSEVIER The effect of early cognitive therapy in improving cognitive functions using neuropsychology and diffusion tensor imaging measurements following mild traumatic brain injury: A pilot study 2018 Amsterdam [u.a.] (DE-627)ELV000241849 volume:162 year:2022 pages:1-10 extent:10 https://doi.org/10.1016/j.ejca.2021.11.013 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.52 Therapie Medizin VZ AR 162 2022 1-10 10 |
| language |
English |
| source |
Enthalten in The effect of early cognitive therapy in improving cognitive functions using neuropsychology and diffusion tensor imaging measurements following mild traumatic brain injury: A pilot study Amsterdam [u.a.] volume:162 year:2022 pages:1-10 extent:10 |
| sourceStr |
Enthalten in The effect of early cognitive therapy in improving cognitive functions using neuropsychology and diffusion tensor imaging measurements following mild traumatic brain injury: A pilot study Amsterdam [u.a.] volume:162 year:2022 pages:1-10 extent:10 |
| format_phy_str_mv |
Article |
| bklname |
Therapie |
| institution |
findex.gbv.de |
| topic_facet |
and PD-L1 expression Durvalumab Tumour-infiltrated lymphocytes CD8 Locally advanced non-small-cell carcinoma |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
The effect of early cognitive therapy in improving cognitive functions using neuropsychology and diffusion tensor imaging measurements following mild traumatic brain injury: A pilot study |
| authorswithroles_txt_mv |
Shirasawa, Masayuki @@aut@@ Yoshida, Tatsuya @@oth@@ Imabayashi, Tatsuya @@oth@@ Okuma, Kae @@oth@@ Matsumoto, Yuji @@oth@@ Masuda, Ken @@oth@@ Shinno, Yuki @@oth@@ Okuma, Yusuke @@oth@@ Goto, Yasushi @@oth@@ Horinouchi, Hidehito @@oth@@ Tsuchida, Takaaki @@oth@@ Yamamoto, Noboru @@oth@@ Nakayama, Yuko @@oth@@ Watanabe, Shun-ichi @@oth@@ Motoi, Noriko @@oth@@ Ohe, Yuichiro @@oth@@ |
| publishDateDaySort_date |
2022-01-01T00:00:00Z |
| hierarchy_top_id |
ELV000241849 |
| dewey-sort |
3610 |
| id |
ELV056678592 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV056678592</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624233618.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">220205s2022 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.ejca.2021.11.013</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001685.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV056678592</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0959-8049(21)01219-3</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.52</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Shirasawa, Masayuki</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Baseline PD-L1 expression and tumour-infiltrated lymphocyte status predict the efficacy of durvalumab consolidation therapy after chemoradiotherapy in unresectable locally advanced patients with non-small-cell lung cancer</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2022</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">10</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Chemoradiotherapy (CRT) followed by durvalumab treatment improved prognosis in unresectable locally advanced non-small-cell lung cancer (LA-NSCLC). This study aimed to evaluate whether the status of the immune-related tumour microenvironment (TME) at baseline associates with the efficacy.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">and PD-L1 expression</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Durvalumab</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Tumour-infiltrated lymphocytes</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">CD8</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Locally advanced non-small-cell carcinoma</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Yoshida, Tatsuya</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Imabayashi, Tatsuya</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Okuma, Kae</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Matsumoto, Yuji</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Masuda, Ken</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Shinno, Yuki</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Okuma, Yusuke</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Goto, Yasushi</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Horinouchi, Hidehito</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Tsuchida, Takaaki</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Yamamoto, Noboru</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nakayama, Yuko</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Watanabe, Shun-ichi</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Motoi, Noriko</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ohe, Yuichiro</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Hamzah, N. ELSEVIER</subfield><subfield code="t">The effect of early cognitive therapy in improving cognitive functions using neuropsychology and diffusion tensor imaging measurements following mild traumatic brain injury: A pilot study</subfield><subfield code="d">2018</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV000241849</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:162</subfield><subfield code="g">year:2022</subfield><subfield code="g">pages:1-10</subfield><subfield code="g">extent:10</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.ejca.2021.11.013</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.52</subfield><subfield code="j">Therapie</subfield><subfield code="x">Medizin</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">162</subfield><subfield code="j">2022</subfield><subfield code="h">1-10</subfield><subfield code="g">10</subfield></datafield></record></collection>
|
| author |
Shirasawa, Masayuki |
| spellingShingle |
Shirasawa, Masayuki ddc 610 bkl 44.52 Elsevier and PD-L1 expression Elsevier Durvalumab Elsevier Tumour-infiltrated lymphocytes Elsevier CD8 Elsevier Locally advanced non-small-cell carcinoma Baseline PD-L1 expression and tumour-infiltrated lymphocyte status predict the efficacy of durvalumab consolidation therapy after chemoradiotherapy in unresectable locally advanced patients with non-small-cell lung cancer |
| authorStr |
Shirasawa, Masayuki |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV000241849 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 VZ 44.52 bkl Baseline PD-L1 expression and tumour-infiltrated lymphocyte status predict the efficacy of durvalumab consolidation therapy after chemoradiotherapy in unresectable locally advanced patients with non-small-cell lung cancer and PD-L1 expression Elsevier Durvalumab Elsevier Tumour-infiltrated lymphocytes Elsevier CD8 Elsevier Locally advanced non-small-cell carcinoma Elsevier |
| topic |
ddc 610 bkl 44.52 Elsevier and PD-L1 expression Elsevier Durvalumab Elsevier Tumour-infiltrated lymphocytes Elsevier CD8 Elsevier Locally advanced non-small-cell carcinoma |
| topic_unstemmed |
ddc 610 bkl 44.52 Elsevier and PD-L1 expression Elsevier Durvalumab Elsevier Tumour-infiltrated lymphocytes Elsevier CD8 Elsevier Locally advanced non-small-cell carcinoma |
| topic_browse |
ddc 610 bkl 44.52 Elsevier and PD-L1 expression Elsevier Durvalumab Elsevier Tumour-infiltrated lymphocytes Elsevier CD8 Elsevier Locally advanced non-small-cell carcinoma |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
t y ty t i ti k o ko y m ym k m km y s ys y o yo y g yg h h hh t t tt n y ny y n yn s i w siw n m nm y o yo |
| hierarchy_parent_title |
The effect of early cognitive therapy in improving cognitive functions using neuropsychology and diffusion tensor imaging measurements following mild traumatic brain injury: A pilot study |
| hierarchy_parent_id |
ELV000241849 |
| dewey-tens |
610 - Medicine & health |
| hierarchy_top_title |
The effect of early cognitive therapy in improving cognitive functions using neuropsychology and diffusion tensor imaging measurements following mild traumatic brain injury: A pilot study |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV000241849 |
| title |
Baseline PD-L1 expression and tumour-infiltrated lymphocyte status predict the efficacy of durvalumab consolidation therapy after chemoradiotherapy in unresectable locally advanced patients with non-small-cell lung cancer |
| ctrlnum |
(DE-627)ELV056678592 (ELSEVIER)S0959-8049(21)01219-3 |
| title_full |
Baseline PD-L1 expression and tumour-infiltrated lymphocyte status predict the efficacy of durvalumab consolidation therapy after chemoradiotherapy in unresectable locally advanced patients with non-small-cell lung cancer |
| author_sort |
Shirasawa, Masayuki |
| journal |
The effect of early cognitive therapy in improving cognitive functions using neuropsychology and diffusion tensor imaging measurements following mild traumatic brain injury: A pilot study |
| journalStr |
The effect of early cognitive therapy in improving cognitive functions using neuropsychology and diffusion tensor imaging measurements following mild traumatic brain injury: A pilot study |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology |
| recordtype |
marc |
| publishDateSort |
2022 |
| contenttype_str_mv |
zzz |
| container_start_page |
1 |
| author_browse |
Shirasawa, Masayuki |
| container_volume |
162 |
| physical |
10 |
| class |
610 VZ 44.52 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Shirasawa, Masayuki |
| doi_str_mv |
10.1016/j.ejca.2021.11.013 |
| dewey-full |
610 |
| title_sort |
baseline pd-l1 expression and tumour-infiltrated lymphocyte status predict the efficacy of durvalumab consolidation therapy after chemoradiotherapy in unresectable locally advanced patients with non-small-cell lung cancer |
| title_auth |
Baseline PD-L1 expression and tumour-infiltrated lymphocyte status predict the efficacy of durvalumab consolidation therapy after chemoradiotherapy in unresectable locally advanced patients with non-small-cell lung cancer |
| abstract |
Chemoradiotherapy (CRT) followed by durvalumab treatment improved prognosis in unresectable locally advanced non-small-cell lung cancer (LA-NSCLC). This study aimed to evaluate whether the status of the immune-related tumour microenvironment (TME) at baseline associates with the efficacy. |
| abstractGer |
Chemoradiotherapy (CRT) followed by durvalumab treatment improved prognosis in unresectable locally advanced non-small-cell lung cancer (LA-NSCLC). This study aimed to evaluate whether the status of the immune-related tumour microenvironment (TME) at baseline associates with the efficacy. |
| abstract_unstemmed |
Chemoradiotherapy (CRT) followed by durvalumab treatment improved prognosis in unresectable locally advanced non-small-cell lung cancer (LA-NSCLC). This study aimed to evaluate whether the status of the immune-related tumour microenvironment (TME) at baseline associates with the efficacy. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U |
| title_short |
Baseline PD-L1 expression and tumour-infiltrated lymphocyte status predict the efficacy of durvalumab consolidation therapy after chemoradiotherapy in unresectable locally advanced patients with non-small-cell lung cancer |
| url |
https://doi.org/10.1016/j.ejca.2021.11.013 |
| remote_bool |
true |
| author2 |
Yoshida, Tatsuya Imabayashi, Tatsuya Okuma, Kae Matsumoto, Yuji Masuda, Ken Shinno, Yuki Okuma, Yusuke Goto, Yasushi Horinouchi, Hidehito Tsuchida, Takaaki Yamamoto, Noboru Nakayama, Yuko Watanabe, Shun-ichi Motoi, Noriko Ohe, Yuichiro |
| author2Str |
Yoshida, Tatsuya Imabayashi, Tatsuya Okuma, Kae Matsumoto, Yuji Masuda, Ken Shinno, Yuki Okuma, Yusuke Goto, Yasushi Horinouchi, Hidehito Tsuchida, Takaaki Yamamoto, Noboru Nakayama, Yuko Watanabe, Shun-ichi Motoi, Noriko Ohe, Yuichiro |
| ppnlink |
ELV000241849 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth |
| doi_str |
10.1016/j.ejca.2021.11.013 |
| up_date |
2024-07-06T21:05:24.521Z |
| _version_ |
1803865213655580672 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV056678592</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624233618.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">220205s2022 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.ejca.2021.11.013</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001685.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV056678592</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0959-8049(21)01219-3</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.52</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Shirasawa, Masayuki</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Baseline PD-L1 expression and tumour-infiltrated lymphocyte status predict the efficacy of durvalumab consolidation therapy after chemoradiotherapy in unresectable locally advanced patients with non-small-cell lung cancer</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2022</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">10</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Chemoradiotherapy (CRT) followed by durvalumab treatment improved prognosis in unresectable locally advanced non-small-cell lung cancer (LA-NSCLC). This study aimed to evaluate whether the status of the immune-related tumour microenvironment (TME) at baseline associates with the efficacy.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">and PD-L1 expression</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Durvalumab</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Tumour-infiltrated lymphocytes</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">CD8</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Locally advanced non-small-cell carcinoma</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Yoshida, Tatsuya</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Imabayashi, Tatsuya</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Okuma, Kae</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Matsumoto, Yuji</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Masuda, Ken</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Shinno, Yuki</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Okuma, Yusuke</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Goto, Yasushi</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Horinouchi, Hidehito</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Tsuchida, Takaaki</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Yamamoto, Noboru</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nakayama, Yuko</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Watanabe, Shun-ichi</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Motoi, Noriko</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ohe, Yuichiro</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Hamzah, N. ELSEVIER</subfield><subfield code="t">The effect of early cognitive therapy in improving cognitive functions using neuropsychology and diffusion tensor imaging measurements following mild traumatic brain injury: A pilot study</subfield><subfield code="d">2018</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV000241849</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:162</subfield><subfield code="g">year:2022</subfield><subfield code="g">pages:1-10</subfield><subfield code="g">extent:10</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.ejca.2021.11.013</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.52</subfield><subfield code="j">Therapie</subfield><subfield code="x">Medizin</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">162</subfield><subfield code="j">2022</subfield><subfield code="h">1-10</subfield><subfield code="g">10</subfield></datafield></record></collection>
|
| score |
7.400853 |